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implications on lung function and hospitalizations
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Objectives: Aspergillus spp. (Asp) or Candida spp. (CA) isolation from sputum
samples in CF children is common, but with yet unclear signiﬁcance.
We studied Asp and CA isolation from respiratory secretions in CF children and
their effect on lung function and hospitalizations.
Methods: 8-year retrospective cohort study of 121 CF children (3,601 sputum sam-
ples). Isolation was deﬁned as the presence of at least one positive culture. Multiple
regressions assessed the effect on spirometry results and hospitalizations on study
completion after adjustment for 10 confounders whereas simple comparisons were
also performed.
Asp (33.1%) was associated with genotype (p = 0.041), BMI (p = 0.037), pan-
creatic insufﬁciency (p = 0.005), ABPA (p = 0.006), pos corticosteroids >3months
(p = 0.038), pos antifungal (p< 0.001), azithromycin (p = 0.021) and rhDNase
(p = 0.008). CA (71.1%) was associated with weight (p = 0.042), pancreatic in-
sufﬁciency (p< 0.001), CFRD (p = 0.040), ABPA (p = 0.003), P. aeruginosa col-
onization (p = 0.006), Asp (p = 0.005), pos corticosteroids >3months (p< 0.001),
inh corticosteroids >3months (p = 0.030), pos antifungal (p = 0.006) and rhDNase
(p = 0.017). Asp was associated with FVC %predicted (b =−11.739, SE = 5.737,
p = 0.045), FEV1%predicted (b =−14.734, SE = 6.598, p = 0.029) and hospitaliza-
tions (b = 2.458, SE = 0.916, p = 0.009) after adjustment for confounders while CA
wasn’t. But, there was a trend toward signiﬁcance for hospitalizations (b = 2.230,
SE = 1.200, p = 0.068).
Conclusions: Asp in respiratory secretions in CF children is associated with a
decline in lung function and an increase in hospitalizations while CA tends to
increase hospitalizations.
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Purpose: Aspergillus fumigatus is an increasingly important pathogen within the
lungs of Cystic Fibrosis (CF) patients. Recent clinical data indicates deteriorating
lung function in CF patients containing where both of these organisms. The aim of
this study was to investigate whether co-culture of these two species inﬂuences the
pathogenic potential of P. aeruginosa.
Methods: Pseudomonas aeruginosa (wild type, mucoid and non-mucoid) and
Af293 (live/dead 24h bioﬁlms) were co-incubated and supernatants collected after
0, 0.5, 1, 2, 4, 8 and 24h. An elastin congo red assay was optimised to assess the
elastase activity of P. aeruginosa ± A. fumigatus. Exogenous elastin was used as
positive control and to produce the standard curve.
Results: The elastase activity of P. aeruginosa was strain dependant, with mucoid
strains producing more elastase than non-mucoid strains. Overnight co-culture of
PA14 with both live and dead Af293 signiﬁcantly up regulated elastase activity
compared to PA14 alone control (P< 0.001). The kinetics of elastase production
in the presence of Af293 showed a signiﬁcant time dependant increase in elastase
activity over the period of incubation time (P< 0.001).
Conclusion: In this study we have demonstrated that the presence of the fungal
pathogen A. fumigatus causes an upregulation in elastase activity in P. aeruginosa.
This enzyme is a key virulence factor of P. aeruginosa, causing proteolytic damage
to tissue, thus contributing to overall deterioration of lung function which may
explain why patients with these two pathogens have poorer clinical outcomes.
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Wildtype clinical and reference bacterial isolates are an extremely important asset
and resource for academic clinicians and researchers within CF. Our historical
experience is that physical isolate/strain repositories (both CF and others) are
expensive and difﬁcult to maintain and manage. Sufﬁcient resource already exists
within National Reference Collections of organisms throughout Europe including
CRBIP, Institute Pasteur (France), BCCM (Belgium), CBS (The Netherlands),
DSMZ (Germany), IST (Italy) and the National Collection of Type Cultures (UK)
for the provision of Reference/Type CF strains. To date, provision of wildtype
clinical isolates resides with clinical microbiology in hospitals serving European
CF Centres and are not well characterised in any consolidated manner, resulting
in an ad hoc collection of isolates throughout Europe with poor visability and
exploitability. CF MicroARK has established an on-line resource hosted at the CF
Association of Ireland website (www.cﬁreland.ie) for the beneﬁt of CF researchers
in Ireland, Europe and beyond. The project has e-captured all available wildtype
isolates that physically exists in culture archives at CF centres throughout the Island
of Ireland and has catalogued these within various CF-speciﬁc databases. Ownership
of the CF isolates remains with the custodians of the host laboratory, where they
currently reside in a variety of laboratories and depositing laboratories have the
ability to administer and update their catalogue independently. It is hoped that
CF MicroARK now becomes a vibrant and dynamic gateway for the exchange of
wildtype isolates within the CF research community.
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Introduction: Burkholderia pseudomallei has been described in patients living and
visiting tropical climates and geographical differences in Pseudomonas aeruginosa
have also been reported [1,2]. The Prince Charles Hospital CF centre serves patients
from an area of ~1.8 million km2, half of which lies north of the Tropic of Capricorn
where 17.9% of our patients reside.
Methods: Sputum microbiology from all samples processed in the previous 10 years
from patients living in tropical Australia (n = 69) was compared with those from
sub-tropical regions and with data from the Australian CF Data Registry (ACFDR).
The data included patients who were alive, deceased and had been transplanted as
of December 2011.
Results: Isolation of non-tuberculous mycobacteria (NTM) ever was elevated
in tropical patients (24.6% compared with 8.2% subtropical patients, c2 = 13,
p = 0.0003 and <1% of the ACFDR). Burkholderia cepacia complex (Bcc) was
reported in 17.9% of tropical patients compared with 11.1% subtropical patients
(not signiﬁcant) and 7.4% of the ACFDR. Isolation of Burkholderia pseudomallei
was elevated in the tropical group (7.3% compared with 0.6% of the subtropical
group, c2 = 13.9, p = 0.0002). Rates of S. aureus, MRSA and P. aeruginosa were
comparable to the subtropical patients and the ACFDR, however Aspergillus sp.
was more commonly isolated in the tropics (53% of patients compared with 14%
ACFDR).
Conclusions: Patients residing in tropical Australia have higher detection rates of
NTM, B. pseudomallei and Aspergillus sp than subtropical patients attending TPCH
or the Australian CF population as a whole.
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